An artificial device reproducing a 1:1 scale model of the blood-brain barrier (BBB) was fabricated by a research team at IIT-Istituto Italiano di Tecnologia. BBB is the anatomical and functional structure that protects the central nervous system from external substances, such as contaminants, but also drugs when they are injected intravenously into the body. The device, which is a combination of artificial and biological components, will be fundamental for studying new therapeutic strategies to overcome blood-brain barrier and treat brain diseases, such as tumors.
The study was coordinated by Gianni Ciofani, researcher at IIT in Pontedera (Pisa) and Professor at Politecnico di Torino, in the framework of the research project SLaMM funded by the European Research Council (ERC) and aiming at developing new nanotechnologies for the treatment of brain diseases.
Study Identifies How Immune Cells Cross the Blood-brain Barrier
Study shows for the first time in live animals in real-time, the different means by which two distinct immune cell types gain access to myelin and nerves.
Advertisement
‘Nanotech device that mimics the blood-brain barrier could help study new therapeutic strategies to overcome blood-brain barrier and treat brain diseases.’
Tweet it Now
The device is described in a paper published by the scientific journal Small and highlighted by the journal inside cover: it is a microfluidic device that combines artificial components made with 3-D advanced microfabrication techniques (two-photon lithography) and biological ones, that is endothelial cells (the cells covering blood vessels).
The microprinting was realized with advanced 3D printing technologies (Nanoscribe) that make use of a laser that scans through a liquid photopolymer and solidifies the material locally and layer by layer building complex 3D objects with submicron resolution. Using this manufacturing technique researchers were able to engineer an accurate real-scale model of the BBB made from a photopolymer resin. Mimicking the brain microcapillaries, the model consists of a microfluidic system of 50 parallel cylindrical channels connected by junctions and featuring pores on the cylinder walls. Each of the tubular structures has a diameter of 10 μm and pores of 1 μm diameter uniformly distributed on all cylinders. After the fabrication of the complex scaffold-like polymer structure, endothelial cells were cultivated around the porous microcapillary system. Covering the 3D printed structure, the cells built a biological barrier resulting in a biohybrid system which resembles its natural model. The device is few millimeters big and fluids can pass through it at the same pressure as blood in brain vessels.
![Scientists Discover New Cancer Drug That Can Pass the Blood-Brain Barrier]( "Scientists Discover New Cancer Drug That Can Pass the Blood-Brain Barrier")
A research on the experimental cancer drug that is capable of passing through the blood -brain barrier was studied.
The prototype has been developed owing to an extremely multidisciplinary approach that was based on micro- nanofabrication competencies, modeling and microfluidodynamics.
In the future researchers will use the device to understand the interaction of drugs or of drug delivery nano-vectors to overcome the blood-brain barrier and target the central nervous system. The main goal is to find new therapeutic strategies for the treatment of brain cancer and brain diseases, such as Alzheimer and multiple sclerosis.
Source: Eurekalert
Scientists Discover New Cancer Drug That Can Pass the Blood-Brain Barrier
A research on the experimental cancer drug that is capable of passing through the blood -brain barrier was studied.
Advertisement
The prototype has been developed owing to an extremely multidisciplinary approach that was based on micro- nanofabrication competencies, modeling and microfluidodynamics.
In the future researchers will use the device to understand the interaction of drugs or of drug delivery nano-vectors to overcome the blood-brain barrier and target the central nervous system. The main goal is to find new therapeutic strategies for the treatment of brain cancer and brain diseases, such as Alzheimer and multiple sclerosis.
Source: Eurekalert
Optimizing Small Molecule Blood-Brain Barrier Penetration
The success rate to achieve clinical approval of drugs target to central nervous system (CNS) indications is the lowest of all disease states.
Advertisement
 Blood-brain Barrier Leakage Linked to Alzheimer's DiseaseThe blood brain barrier regulates the delivery of important nutrients and blocks neurotoxins, while removing surplus substances from the brain. | Advertisement
|
Advertisement
Latest Medical Gadgets
Digital Media Overuse Scale is a collection of psychologically oriented questions that doctors and scientists can use to gauge digital media addiction.
Blind individuals utilize the specific area in the brain to recognize basic faces, a function vital for sighted face processing.
Nerivio, the first-of-its-kind product for migraine in India, holds USFDA approval, is drug-free, noninvasive, and exhibits a promising safety profile.
Health-sensing wearables revolutionize healthcare, empowering control. They aid remote patient monitoring, track vital signs like heart rate, glucose, blood pressure.
The Celero Systems capsule, designed for diagnosing sleep apnea, also holds potential in detecting opioid overdoses among high-risk individuals.